Stay updated on Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.6%
    Check dated 2025-07-04T04:13:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.5%
    Check dated 2025-06-19T19:58:31.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:21:42.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.8%
    Check dated 2025-05-29T06:07:58.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T14:24:25.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed background information on locally advanced head and neck cancer and the addition of a new study titled 'Phase II Non-Randomised Controlled Trial Of Concomitant Immune Check Point Inhibitor With Radiotherapy And Chemotherapy Or Cetuximab In Advanced Non Metastatic Head And Neck Cancer'.
    Difference
    41%
    Check dated 2025-04-16T10:40:50.000Z thumbnail image

Stay in the know with updates to Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Checkpoint Inhibitor+Chemoradiation in Head and Neck Cancer Clinical Trial page.